CD4 and B-cell chronic lymphocytic leukemia: Further, expansion of a novel CD4+ T subpopulation characterized by the expression of the TIGIT (T cell immunoreceptor with Ig and ITIM domains) inhibitory receptor has been recently observed in patients at advanced stages of CLL; these cells were shown to support CLL survival in in vitro experiments (36).